Cellcolabs Clinical SPV Limited
3 clinical trials · Sponsor
◉ Watch Cellcolabs Clinical SPV Limited
| Record | Firm | Date |
|---|---|---|
| An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis (NCT07542808) | Cellcolabs Clinical SPV Limited | 2026-04-27 |
| A Study to Evaluate Allogenic Bone-Marrow Mesenchymal Stromal Cell Product StromaForte in Aging Frailty Patients (NCT06063590) | Cellcolabs Clinical SPV Limited | 2024-01-22 |
| A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis (NCT06084988) | Cellcolabs Clinical SPV Limited | 2023-11-07 |
Track Cellcolabs Clinical SPV Limited automatically
Every clearance here is in the API, with alerts when new ones post.